Omeros Corporation
General ticker "OMER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $468.1M (TTM average)
Omeros Corporation follows the US Stock Market performance with the rate: 45.4%.
Estimated limits based on current volatility of 2.6%: low 10.15$, high 10.69$
Factors to consider:
- Total employees count: 198 (-6.2%) as of 2023
- Top business risk factors: Cumulative operating losses, Operational and conduct risks, Regulatory and compliance, Litigation risks, Liquidity and credit risks
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.24$, 17.81$]
- 2026-12-31 to 2027-12-31 estimated range: [5.06$, 14.71$]
Financial Metrics affecting the OMER estimates:
- Positive: with PPE of 7.2 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of -37.23 <= 19.24
- Positive: Investing cash flow per share per price, % of 20.30 > -0.60
- Negative: 0.01 < Interest expense per share per price, % of 0.12
- Negative: Industry earnings per price (median), % of -13.66 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term OMER quotes
Long-term OMER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $164.53MM | $169.26MM | $122.80MM |
| Operating Income | $-164.53MM | $-169.26MM | $-122.80MM |
| Non-Operating Income | $-10.39MM | $-13.37MM | $120.00MM |
| Interest Expense | $30.84MM | $24.68MM | $0.96MM |
| R&D Expense | $114.87MM | $119.52MM | $81.30MM |
| Income(Loss) | $-174.92MM | $-182.63MM | $-2.80MM |
| Taxes | $0.00MM | $0.00MM | $2.01MM |
| Other Income(Loss) | $57.11MM | $25.81MM | $1.46MM |
| Net Income(Loss)* | $-60.71MM | $-156.81MM | $-1.89MM |
| Stockholders Equity | $-24.98MM | $-182.61MM | $-121.23MM |
| Assets | $378.27MM | $277.08MM | $325.63MM |
| Operating Cash Flow | $74.73MM | $-148.80MM | $-116.09MM |
| Capital expenditure | $0.43MM | $0.17MM | $0.07MM |
| Investing Cash Flow | $27.45MM | $82.22MM | $164.52MM |
| Financing Cash Flow | $-106.08MM | $62.88MM | $-42.17MM |
| Earnings Per Share** | $-0.97 | $-2.70 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.